Current partner codePEPTIDESDE
Evidence dashboardStudies since 1997Updated Jul 31, 2026

SincalideClinical Trials.

A source-linked view of every Sincalide study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials
10
Recruiting
1
Completed
7
Terminated
1
Results posted
3
Average enrollment
46
Countries
4
Highest phase
Phase 4

Developer / research origin

Bracco Diagnostics

Evidence summary

Activity is not efficacy.

Sincalide appears in 10 indexed studies: 1 recruiting, 7 completed and 3 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Sincalide is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

19972026

Velocity

Sincalide studies by start year

Study start year · indexed snapshot

3221019971997: 1 trials1998: 0 trials1999: 0 trials2000: 0 trials2001: 0 trials20022002: 0 trials2003: 0 trials2004: 0 trials2005: 0 trials2006: 0 trials20072007: 0 trials2008: 3 trials2009: 0 trials2010: 0 trials2011: 0 trials20122012: 2 trials2013: 0 trials2014: 0 trials2015: 1 trials2016: 0 trials20172017: 0 trials2018: 0 trials2019: 0 trials2020: 1 trials2021: 0 trials20222022: 0 trials2023: 0 trials2024: 0 trials2025: 1 trials20262026: 1 trials

Development

Trials by phase

Early Phase 10
Phase 12
Phase 20
Phase 31
Phase 41

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

Showing 6 of 7 studies

Full study index

Search Sincalide trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

10 matching studies

End of 10 results

Latest publications

Follow the paper trail.

PMID 18385466Someya N, Endo MY, Fukuba Y, Hayashi N. Blood flow responses in celiac and superior mesenteric arteries in the initial phase of digestion. Am J Physiol Regul Integr Comp Physiol. 2008 Jun;294(6):R1790-6. doi: 10.1152/ajpregu.00553.2007. Epub 2008 Apr 2.Linked from NCT07019519PMID 7614106Parker DR, Carlisle K, Cowan FJ, Corrall RJ, Read AE. Postprandial mesenteric blood flow in humans: relationship to endogenous gastrointestinal hormone secretion and energy content of food. Eur J Gastroenterol Hepatol. 1995 May;7(5):435-40.Linked from NCT07019519PMID 31369335Randall EB, Billeschou A, Brinth LS, Mehlsen J, Olufsen MS. A model-based analysis of autonomic nervous function in response to the Valsalva maneuver. J Appl Physiol (1985). 2019 Nov 1;127(5):1386-1402. doi: 10.1152/japplphysiol.00015.2019. Epub 2019 Aug 1.Linked from NCT07019519PMID 29549458Mehr SE, Barbul A, Shibao CA. Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review. Clin Auton Res. 2018 Aug;28(4):411-421. doi: 10.1007/s10286-018-0519-x. Epub 2018 Mar 16.Linked from NCT07019519PMID 35232225Breier NC, Paranjape SY, Scudder S, Mehr SE, Diedrich A, Flynn CR, Okamoto LE, Hartmann B, Gasbjerg LS, Shibao CA. Worsening Postural Tachycardia Syndrome Is Associated With Increased Glucose-Dependent Insulinotropic Polypeptide Secretion. Hypertension. 2022 May;79(5):e89-e99. doi: 10.1161/HYPERTENSIONAHA.121.17852. Epub 2022 Mar 2.Linked from NCT07019519PMID 28258126Koffert J, Honka H, Teuho J, Kauhanen S, Hurme S, Parkkola R, Oikonen V, Mari A, Lindqvist A, Wierup N, Groop L, Nuutila P. Effects of meal and incretins in the regulation of splanchnic blood flow. Endocr Connect. 2017 Apr;6(3):179-187. doi: 10.1530/EC-17-0015. Epub 2017 Mar 3.Linked from NCT07019519PMID 28667118Asmar M, Asmar A, Simonsen L, Gasbjerg LS, Sparre-Ulrich AH, Rosenkilde MM, Hartmann B, Dela F, Holst JJ, Bulow J. The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor. Diabetes. 2017 Sep;66(9):2363-2371. doi: 10.2337/db17-0480. Epub 2017 Jun 30.Linked from NCT07019519PMID 20547981Asmar M, Simonsen L, Madsbad S, Stallknecht B, Holst JJ, Bulow J. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes. 2010 Sep;59(9):2160-3. doi: 10.2337/db10-0098. Epub 2010 Jun 14.Linked from NCT07019519

Related pages

Keep researching Sincalide.

Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.